Aug 11, 2020
American Society of Ketamine Physicians, Psychotherapists and Practitioners Announces Standards of Practice in the Therapeutic Use of Subanesthetic Ketamine
Jun 22, 2020
LUNGevity and EGFR Resisters Collaborate on Lung Cancer Research Awards
Jun 18, 2020
MindMed To Evaluate Ayahuasca's Active Ingredient DMT In Phase 1 Clinical Trial Collaboration
Jun 03, 2020
The American Society of Ketamine Physicians (ASKP) Announces Name Change
May 29, 2020
Lilly's CYRAMZA® (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
May 27, 2020
The Ketamine Healing Clinic of Los Angeles, California, is Offering New "Fountain of Youth Infusion" with the Combination of NAD and Ketamine
May 26, 2020
Bexson Biomedical Announces Two New Appointments to Board of Directors
May 07, 2020
CaaMTech Collaborates With National Institutes of Health to Research Psychedelics
Apr 28, 2020
Impact of COVID-19 on the Chinese Pesticide Industry - ResearchAndMarkets.com
Apr 03, 2020
Global Levamlodipine Besylate Markets, 2020 - ResearchAndMarkets.com
Mar 27, 2020
Amlodipine Maleate Market Insights, 2020 - Worldwide Applications, Manufacturers & Distributors, Prices, End-users, and Downstream Sectors
Mar 26, 2020
Phthaloyl Amlodipine | Global Market Study 2020: Trends & Developments, Major Players, Patents, and More - ResearchAndMarkets.com
Mar 26, 2020
2020 Sertraline Markets: Trends & Developments, Major Players, Patents, and More
Mar 25, 2020
Global Amlodipine Besylate Market Insights, 2020: Applications, Manufacturers & Distributors, Prices, End-users, and Downstream Industry Trends - ResearchAndMarkets.com
Mar 25, 2020
Amlodipine (CAS 88150-42-9) Industry Insights, 2020 - Applications, Manufacturers & Distributors, Prices, End-users, and Downstream Industries Trends - ResearchAndMarkets.com
Mar 24, 2020
Cell>Point plans to expedite research program on 99mTc-EC-Amifostine and 177Lu-EC-Amifostine as a potentially effective theranostic technology for COVID-19
Mar 23, 2020
Ketamine Therapy Essential Service During COVID-19 Pandemic
Mar 19, 2020
Hoth Therapeutics Announces Positive Preclinical Data of WEG232 Treatment, Developed for Cancer Patients Suffering from Erlotinib-Induced Facial Dermatitis and Hair Loss
Mar 09, 2020
D'Amore Healthcare Offers Ketamine Therapy
Mar 04, 2020
Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL Fill/2mL Vials Due to the Potential Presence of Small Particulates